High rate of loss to follow-up among patients undergoing treatment for premalignant cervical lesions at Mbarara Regional Referral Hospital, South Western Uganda; a retrospective cohort study

Author:

Kajabwangu Rogers1,Ssedyabane Frank1,Tusubira Deusdedit1,Maling Samuel1,Kakongi Nathan1,Turyakira Eleanor1,Namuli Alexcer2,Galiwango Martin1,Randall Thomas C3

Affiliation:

1. Mbarara University of Science of Science and Technology

2. Mbarara Regional Referral Hospital

3. Massachusetts General Hospital

Abstract

Abstract Background For a cervical cancer control program to be effective in reducing incidence of the disease, there should be a high compliance to treatment and follow-up of the women diagnosed with precursor lesions. Screening programs in low-resource countries like Uganda are challenged by poor adherence to follow-up following treatment for premalignant cervical lesions. This study sought to describe the burden and factors associated with loss to follow-up among women undergoing treatment for premalignant cervical lesions at a tertiary hospital in south-western UgandaMethods This was a retrospective cohort study. We reviewed the registers at the Mbarara Regional Referral Hospital cervical cancer clinic for a period of four years from January 2017 to December 2020. Data was collected on; age, district of residence, diagnosis, date of diagnosis, date and type of initial treatment as well as date of follow up visit. We also captured data on whether patients returned on the scheduled follow up date or within three months after the scheduled follow up date. We defined loss to follow-up as failure to return for follow up either on the scheduled date or within three months after the scheduled date.Results Out of the 298 patients who underwent treatment for premalignant cervical lesions in the study period, 227(76.2%) did not return for follow-up at one year. At bivariate analysis, failure to attend the review visit at 6weeks predicted the loss to follow up at one year following treatment for premalignant lesions almost perfectly (RR = 2.84, 95% CI: 2.18–3.71, p-value < 0.001). Negative HIV serostatus and receiving thermocoagulation, slightly increased the risk of getting lost to follow-up while being more than 45years old reduced the odds. At multi-variate analysis, treatment with thermocoagulation (ARR = 1.21, 95% CI:1.07,1.36, p-value-0.03) was associated with loss to follow-up at one year.Conclusion The proportion of women who don’t return for follow-up at one year following treatment for premalignant cervical lesions at Mbarara regional referral hospital is very high. There is need to implement strategies that prompt patients to return for follow-up following treatment for premalignant cervical lesions.

Publisher

Research Square Platform LLC

Reference34 articles.

1. Cancer of the cervix uteri: 2021 update;Bhatla N;Int J Gynecol Obstet,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;Cancer J Clin,2021

3. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis;Arbyn M;The Lancet Global Health,2020

4. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost;Yang BH;Int J Cancer,2004

5. Group on the evaluation of carcinogenic risks to humans. Human papillomaviruses;Working I;IARC Monogr Eval Carcinog Risks Hum,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3